Pancreatic Cancer Treatment with IntraOp® Mobetron®

2 Views

07/30/23

Mobetron: The Surgical Alternative for More Patients with Pancreatic Cancer
#pancreaticcancer #pancreas #cancer
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp Mobetron and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of survival.

With IORT, oncologists apply an ablative dose of radiation therapy during surgery to manage positive margins, microscopic disease, as well as gross residual tumor—improving local control and survival in patients. IntraOp’s portable, self-shielded Mobetron linear accelerator makes IORT faster, more precise, and more economical than ever before, such that IORT can be delivered in virtually any operating theater.